linkedin
 
You Are On
Equity
Equity Analysis
News Analysis
Corporate Action
Corporate Info
Derivatives
Other Market
Research
 
 Company Background  
Cohance Lifesciences Ltd.
 
Industry : Pharmaceuticals & Drugs House : Private
BSE Code 543064
ISIN Demat INE03QK01018
Book Value 115.25
NSE Code COHANCE
Dividend Yield % 0.00
Market Cap 205553.32
P/E 74.06
EPS 7.25
Face Value 1  
 
Incorporation Year 06-11 2018  
Registered Office 215 Atrium, C Wing, 8th Floor, 819-821,Andheri, Kurla Road, Chakala,Andheri (East), Chakala Midc, Mumbai,
Maharashtra-400093 .
ISINNO INE03QK01018  
Phone 022-61539999  
E-mail info@suvenpharm.com
URL www.cohance.com
Industry Pharmaceuticals & Drugs  
Chairman Vivek Sharma  
Managing Director  
Company Secretary Kundan Kumar Jha  
Listing BSE,NSE  
 
RMS | Policies & Procedures| PMLA | Disclaimer | Privacy Policy | Web Mail | Relationship | Investor Grievance
Career | Contact Us| KYC| PMS Risk Disclosure | Key Managerial Person | Basic Details | Process of Opening an Account | Process of Filing Complaint
Links to MCX | NCDEX |FMC | NCDEX CMID NCDEX-CO-04-00129 | MCX 10550 | FMC MCX: MCX/TCM/CORP/0008| FMC NCDEX : NCDEX/TCM/CORP/0274    
NSE: INB230914036 |NSE F & O INF230914036 |BSE: INB010914032 |BSE F & O: INF010914032 | CDSL: IN-DP-CDSL-335-2006 | OTC: INB200914032
Related Sites: Bombay Stock Exchange (BSE), Investor Protection, National Stock Exchange (NSE), Securities & Exchange Board of India (SEBI)
© Padmakshi 2009. All Rights Reserved. Designed || Developed & Content Powered By Accord Fintech Pvt. Ltd.